Aeterna Zentaris Inc. (AEZS): Price and Financial Metrics

Aeterna Zentaris Inc. (AEZS): $4.59

0.03 (-0.65%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add AEZS to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#271 of 387

in industry

AEZS Price/Volume Stats

Current price $4.59 52-week high $12.80
Prev. close $4.62 52-week low $3.96
Day low $3.96 Volume 20,600
Day high $4.96 Avg. volume 6,894
50-day MA $7.83 Dividend yield N/A
200-day MA $7.88 Market Cap 8.23M

AEZS Stock Price Chart Interactive Chart >


Aeterna Zentaris Inc. (AEZS) Company Bio


Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company was founded in 1991 and is based in Summerville, South Carolina.


AEZS Latest News Stream


Event/Time News Detail
Loading, please wait...

AEZS Latest Social Stream


Loading social stream, please wait...

View Full AEZS Social Stream

Latest AEZS News From Around the Web

Below are the latest news stories about AETERNA ZENTARIS INC that investors may wish to consider to help them evaluate AEZS as an investment opportunity.

Aeterna Zentaris Reports Third Quarter 2023 Financial Results

- Launch of Ghryvelin™ in a number of key countries in the European Economic Area - Approval of Macrilen® in South Korea in September - Ended the quarter with $38.8 million in cash, expected to fund operations and advancement of priority pipeline programs into 2025 TORONTO, ONTARIO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmac

Yahoo | November 9, 2023

Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference

– Live moderated webcast with Klaus Paulini, Chief Executive Officer of Aeterna Zentaris on Wednesday, October 25th at 10:00 AM ET TORONTO, ONTARIO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna Zentaris will participate a

Yahoo | October 11, 2023

Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference

TORONTO, ONTARIO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 in New York, NY in person and virtually. Dr. P

Yahoo | September 5, 2023

Aeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimates

Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of 40.23% and 104.18%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 9, 2023

Aeterna Zentaris Reports Second Quarter 2023 Financial Results

Ended the quarter with $42.2 million in cash, expected to fund operations into 2025Driving patient recruitment for Phase 3 DETECT trial for the diagnosis of Childhood Onset Growth Hormone Deficiency TORONTO, ONTARIO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and o

Yahoo | August 9, 2023

Read More 'AEZS' Stories Here

AEZS Price Returns

1-mo -45.16%
3-mo -42.34%
6-mo -36.95%
1-year -57.89%
3-year -94.92%
5-year -98.29%
YTD -38.31%
2023 -41.51%
2022 -64.20%
2021 -16.50%
2020 -53.24%
2019 -69.05%

Continue Researching AEZS

Want to see what other sources are saying about Aeterna Zentaris Inc's financials and stock price? Try the links below:

Aeterna Zentaris Inc (AEZS) Stock Price | Nasdaq
Aeterna Zentaris Inc (AEZS) Stock Quote, History and News - Yahoo Finance
Aeterna Zentaris Inc (AEZS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!